HRT Financial’s Kiniksa Pharmaceuticals KNSA Stock Holding History

HRT Financial’s Portfolio KNSA Stock Details KNSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-51,964	Closed	-$1.44M	–	3346
2025 Q2	$1.44M	Buy	+51,964	New	+$1.32M	0.01%	1077
2025 Q1	–	Sell	-11,668	Closed	-$230K	–	2999
2024 Q4	$230K	Sell	11,668 -9,023	-44%	-$206K	﹤0.01%	1855
2024 Q3	$517K	Buy	20,691 +9,616	+87%	+$234K	﹤0.01%	1571
2024 Q2	$206K	Buy	+11,075	New	+$207K	﹤0.01%	1648
2024 Q1	–	Sell	-74,866	Closed	-$1.31M	–	2723
2023 Q4	$1.31M	Buy	+74,866	New	+$1.23M	0.01%	858
2023 Q1	–	Sell	-39,751	Closed	-$595K	–	2862
2022 Q4	$595K	Buy	+39,751	New	+$579K	0.01%	1301
2022 Q2	–	Sell	-58,874	Closed	-$585K	–	3362
2022 Q1	$585K	Buy	+58,874	New	+$624K	﹤0.01%	1523
2021 Q4	–	Sell	-18,869	Closed	-$214K	–	3671
2021 Q3	$214K	Buy	+18,869	New	+$246K	﹤0.01%	2643
2020 Q1	–	Sell	-32,300	Closed	-$357K	–	1098
2019 Q4	$357K	Buy	+32,300	New	+$281K	0.02%	671

Other funds holding KNSA

Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

Acadian Asset Management

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

Arrowstreet Capital

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return